Literature DB >> 971690

The immunoglobulins in Hodgkin's disease.

D J Wagener, P J Van Munster, C Haanen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 971690     DOI: 10.1016/0014-2964(76)90016-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  8 in total

1.  Immunohistologic detection of immunoglobulins in malignant lymphomas and its value in histopathologic diagnosis.

Authors:  T Radaszkiewicz; H Denk
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-02-09

2.  Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.

Authors:  F Griesinger; L Bergmann; R Barot-Ciorbaru; P S Mitrou
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 3.  Hodgkin's disease and anergy.

Authors:  T A Shiftan; J Mendelsohn
Journal:  Blut       Date:  1979-01-22

4.  Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.

Authors:  S Romagnani; G F Del Prete; E Maggi; G Bellesi; G Biti; P L Rossi Ferrini; M Ricci
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  Defective in vitro antibody production in response to pokeweed mitogen and influenza antigen in patients with Hodgkin's disease.

Authors:  A Sigfusson; J W Babbage; R L Souhami
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

6.  Spectrum of immunodeficiencies with Hodgkin's disease.

Authors:  J J Twomey; A H Laughter; L Rice; R Ford
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

7.  Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies.

Authors:  M S Dorreen; J A Habeshaw; P F Wrigley; T A Lister
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

8.  Serum immunoglobulins G, A, M, D and E concentrations in lymphomas.

Authors:  P L Amlot; L Green
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.